99% Savings - Buy Just @1 Rs X
Symbiva 400 Capsule is a prescription drug, available for use as Capsule. It is typically used for the treatment of Asthma. Other than this, Symbiva 400 Capsule has some other therapeutic uses, which have been discussed ahead.
Medical history of the patient along with age and gender determines the dosage of Symbiva 400 Capsule. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Refer to the dosage section for a detailed discussion.
Common side effects of Symbiva 400 Capsule include Nasopharyngitis, Headache, Back Pain. Besides the aforementioned side effects, there are other adverse effects of Symbiva 400 Capsule as well, which are listed below. Such side effects of Symbiva 400 Capsule normally do not last long and go away once the treatment is completed. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Furthermore, you should know that effect of Symbiva 400 Capsule is Moderate for pregnant women and Moderate for women who are breastfeeding. In addition, Symbiva 400 Capsule's effects on the liver, heart and kidney are discussed below in the Symbiva 400 Capsule related warnings section.
Some other conditions that can be affected by Symbiva 400 Capsule are listed in the contraindications section below.
Additionally, Symbiva 400 Capsule may also adversely react with other medicines. See below for a complete list.
In addition to these precautions, you may also note that Symbiva 400 Capsule is safe while driving, and is is addictive in nature.
Symbiva 400 Capsule is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Symbiva 400 Capsule safe for pregnant women?
Symbiva may have some side effects during pregnancy. Pregnant women should discontinue the use of Symbiva, and talk to their doctor, if they notice any discomfort.
Is the use of Symbiva 400 Capsule safe during breastfeeding?
Women who are breastfeeding can experience some moderate side effects of Symbiva. Immediately discontinue Symbiva if you observe any side effects. Contact your doctor, and restart using it only if your doctor considers it safe for you.
What is the effect of Symbiva 400 Capsule on the Kidneys?
Symbiva does not damage the kidneys.
What is the effect of Symbiva 400 Capsule on the Liver?
Symbiva is not harmful for the liver.
What is the effect of Symbiva 400 Capsule on the Heart?
Symbiva may have mild side effects on the heart. Most people will never see any effect on the heart.
If you are suffering from any of the following diseases, you should not take Symbiva 400 Capsule unless your doctor advises you to do so -
Is this Symbiva 400 Capsule habit forming or addictive?
Symbiva 400 Capsule is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can comfortably use machinery or drive after taking Symbiva 400 Capsule since it will not make you feel sleepy.
Is it safe?
Yes, but consume Symbiva 400 Capsule only on doctor's advice.
Is it able to treat mental disorders?
Symbiva 400 Capsule is unable to treat or cure mental disorders.
Interaction between Food and Symbiva 400 Capsule
Taking Symbiva 400 Capsule with food does not harm your health.
Interaction between Alcohol and Symbiva 400 Capsule
Taking Symbiva 400 Capsule with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Perforomist® (formoterol fumarate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 224
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 595-596
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 356-366
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 231
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Entocort® Ec (budesonide)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Pulmicort Respules™ (budesonide)
Product Description [Internet]: SYMBICORT. AstraZeneca